C07D 217/06
With the ring nitrogen atom acylated by carboxylic or carbonic acids, or
Official title: with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
C07D217/06 (With the ring nitrogen atom acylated by carboxylic or carbonic acids, or) appears on 404 US grants and 440 published applications in this corpus.
Search patents in C07D- Granted patents
- 404
- Published applications
- 440
- Assignees
- 240
- Inventors
- 1,552
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 4 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 5 | 0 |
| 1998 | 15 | 0 |
| 1999 | 13 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 4 |
| 2002 | 10 | 5 |
| 2003 | 7 | 21 |
| 2004 | 8 | 22 |
| 2005 | 14 | 26 |
| 2006 | 12 | 29 |
| 2007 | 21 | 29 |
| 2008 | 11 | 24 |
| 2009 | 18 | 18 |
| 2010 | 16 | 24 |
| 2011 | 13 | 15 |
| 2012 | 14 | 19 |
| 2013 | 17 | 12 |
| 2014 | 21 | 25 |
| 2015 | 16 | 35 |
| 2016 | 14 | 12 |
| 2017 | 7 | 18 |
| 2018 | 12 | 5 |
| 2019 | 12 | 14 |
| 2020 | 6 | 12 |
| 2021 | 5 | 11 |
| 2022 | 5 | 13 |
| 2023 | 6 | 21 |
| 2024 | 4 | 11 |
| 2025 | 9 | 11 |
| 2026 | 8 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors and uses thereof16 Jun 2026US 12,655,150 B2Cedilla Therapeutics, Inc.
- Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof26 May 2026US 12,637,436 B2Sanford Burnham Prebys Medical Discovery Institute
- Chilled compressed air electric vehicle (EV) fast-charge system and method19 May 2026US 12,630,032 B2RSCC Wire & Cable LLC
- Agents for differentiating stem cells and treating cancer19 May 2026US 12,630,512 B2Minerva Biotechnologies Corporation
- Compositions and methods for treatment24 Feb 2026US 12,558,350 B2Bausch + Lomb Ireland Limited
- Compositions comprising inhibitors of microsomal triglyceride transfer protein and apo-b secretion20 Aug 2026US 2026/0240833 A1Redux Therapeutics, LLC
- Mlh1 selective (series 1b) compounds30 Jul 2026US 2026/0217687 A1NeoPhore Limited
- Agent for restoring metal homeostasis25 Jun 2026US 2026/0174721 A1Oxford Antibiotic Group GmbH
- Novel b0at1 inhibitor1 Jan 2026US 2026/0001849 A1Mitsubishi Tanabe Pharma Corporation
- Compounds and methods for yap/tead modulation and indications therefor18 Dec 2025US 2025/0382293 A1Opna Bio SA
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997
- Modulators of ATP-binding cassette transporters105US 8,101,767 B2Vertex Pharmaceuticals Incorporated · 2012
- Modulators of ATP-binding cassette transporters97US 8,324,242 B2Vertex Pharmaceutical Incorporated · 2012
- Modulators of ATP-binding cassette transporters95US 8,354,427 B2Vertex Pharmaceutical Incorporated · 2013